Company Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
28.41 USD -3.30% Intraday chart for Integra LifeSciences Holdings Corporation -10.18% -34.76%

Business Summary

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Number of employees: 3,946

Sales per Business

USD in Million2022Weight2023Weight Delta
Codman Specialty Surgical
68.7 %
1,020 65.5 % 1,059 68.7 % +3.87%
Tissue Technologies
31.3 %
538 34.5 % 483 31.3 % -10.32%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
71.4 %
1,127 72.3 % 1,101 71.4 % -2.31%
Asia Pacific
12.5 %
176 11.3 % 193 12.5 % +9.42%
Europe
10.7 %
171 11.0 % 165 10.7 % -3.32%
Rest of the World
5.4 %
83 5.4 % 83 5.4 % -1.14%

Managers

Managers TitleAgeSince
Chief Executive Officer 59 21-11-30
Director of Finance/CFO 52 23-06-27
Chairman 62 97-11-30
Chief Operating Officer - 19-09-30
Chief Tech/Sci/R&D Officer - 22-12-31
Investor Relations Contact - 13-04-30
Public Communications Contact - 17-03-31
General Counsel - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 05-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 Dec. 11
Chairman 62 97-11-30
Director/Board Member 63 05-12-31
Director/Board Member 79 91-12-31
Director/Board Member 71 13-05-21
Chief Executive Officer 59 21-11-30
Director/Board Member 76 09-03-31
Director/Board Member 53 21-03-31
Director/Board Member 43 22-07-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 91,353,240 67,747,383 ( 74.16 %) 12,751,000 ( 13.96 %) 74.16 %

Shareholders

NameEquities%Valuation
8,515,930 10.89 % 302 M $
Vanguard Fiduciary Trust Co.
8.965 %
7,012,793 8.965 % 249 M $
BlackRock Advisors LLC
7.836 %
6,128,990 7.836 % 217 M $
Eaton Vance Management
6.738 %
5,270,697 6.738 % 187 M $
Capital Research & Management Co. (Global Investors)
5.494 %
4,297,326 5.494 % 152 M $
Wellington Management Co. LLP
4.072 %
3,185,293 4.072 % 113 M $
Cooke & Bieler LP
3.624 %
2,834,604 3.624 % 100 M $
AllianceBernstein LP
3.484 %
2,725,502 3.484 % 97 M $
ClearBridge Investments LLC
3.163 %
2,474,249 3.163 % 88 M $
Champlain Investment Partners LLC
3.114 %
2,435,957 3.114 % 86 M $

Company contact information

Integra LifeSciences Holdings Corp.

1100 Campus Road

08540, Princeton

+609 275 0500

http://www.integralife.com
address Integra LifeSciences Holdings Corporation(IART)
  1. Stock Market
  2. Equities
  3. IART Stock
  4. Company Integra LifeSciences Holdings Corporation